| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120476 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-08 | 2023-10-19 | 194154 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-01-25 | 2024-02-08 | 217237 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-28 | 2024-09-19 | 223853 |
| TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2026-01-08 | 2026-02-19 | 275527 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102898 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2024-10-17 | 2025-06-05 | 240519 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| CANDESARTAN | 4MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12033 |
| MYLAN-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53628 |
| MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
| MYLAN-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-07-03 | 2018-08-11 | 53616 |
| MYLAN-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53611 |
| TEVA-CANDESARTAN | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258724 |